Document Detail


HSP60 as a drug target.
MedLine Citation:
PMID:  22920899     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Heat shock proteins (HSPs) are ubiquitous and evolutionary conserved proteins induced by cell stress. HSP60, in particular, is a typical mitochondrial molecular chaperone that is known to assist nascent polypeptides to reach a native conformation. HSP60 is also known to interact with HSP10. In the last decade, HSP60 has been detected in the cytosol, the cell surface, the extracellular space, and biological fluids. HSP60 elicits potent proinflammatory response in cells of the innate immune system and serves as a danger signal of stressed or damaged cells. As cytosolic HSP60 levels gradually increase or decrease during carcinogenesis in various organs, HSP60 can be used as a biomarker for the diagnosis and prognosis of preneoplastic and neoplastic lesions. In this review, we summarize recent discoveries on the important roles of HSP60 in various diseases ranging from autoimmune diseases to tumors. Furthermore, small molecules targeting HSP60, which were the target of intensive investigations in the last few years, are also summarized. The possibility of utilizing HSP60 as a new drug target for the treatment of certain diseases is examined.
Authors:
Hiroyuki Nakamura; Hidemitsu Minegishi
Related Documents :
23336339 - Caspase-2 and caspase-8 trigger caspase-3 activation following 6-ohda-induced stress in...
24319639 - Improving macrophage responses to therapeutic antibodies by molecular engineering of si...
23587249 - Activation and cell death in human dendritic cells infected with nipah virus.
24739759 - Induction of antigen-specific immunity with a vaccine targeting ny-eso-1 to the dendrit...
23806369 - Lysine-specific demethylase 1 represses thp-1 monocyte-to-macrophage differentiation(02...
24606459 - Effect of tlr4 and b7-h1 on immune escape of urothelial bladder cancer and its clinical...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-16
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Chemistry, Faculty of Science, Gakushuin University. hiroyuki.nakamura@gakushuin.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hsp70s and J Proteins of Plasmodium Parasites Infecting Rodents and Primates: Structure, Function, C...
Next Document:  High-throughput screening identifies small molecule inhibitors of molecular chaperones.